Omalizumab in the Treatment of Allergic Respiratory Disease
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis in Journal of Asthma
- Vol. 43 (2), 87-93
- https://doi.org/10.1080/02770900500497891
Abstract
(2006). Omalizumab in the Treatment of Allergic Respiratory Disease. Journal of Asthma: Vol. 43, No. 2, pp. 87-93.Keywords
This publication has 51 references indexed in Scilit:
- Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Omalizumab-induced reductions in mast cell FcεRI expression and functionJournal of Allergy and Clinical Immunology, 2004
- Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆Journal of Allergy and Clinical Immunology, 2004
- Omalizumab treatment downregulates dendritic cell FcεRI expressionJournal of Allergy and Clinical Immunology, 2003
- Human dendritic cell 1 and dendritic cell 2 subsets express FcεRIJournal of Allergy and Clinical Immunology, 2003
- OmalizumabDrugs, 2001
- Upregulation of FcϵRI on human basophils by IgE antibody is mediated by interaction of IgE with FcϵRIJournal of Allergy and Clinical Immunology, 1999
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- Characterization of Complex Formation by Humanized Anti-IgE Monoclonal Antibody and Monoclonal Human IgEBiochemistry, 1995
- Inhibition of Allergic Reactions with Antibodies to IgEInternational Archives of Allergy and Immunology, 1995